|1.||Kaukola, Tuula: 4 articles (02/2013 - 09/2010)|
|2.||Hallman, Mikko: 4 articles (02/2013 - 09/2010)|
|3.||Tuimala, Jarno: 3 articles (02/2013 - 04/2011)|
|4.||Kingsmore, Stephen F: 3 articles (02/2013 - 09/2010)|
|5.||Ojaniemi, Marja: 3 articles (11/2012 - 09/2010)|
|6.||Kallankari, Hanna: 2 articles (02/2013 - 09/2010)|
|7.||Herva, Riitta: 2 articles (04/2011 - 09/2010)|
|8.||Howie, A J: 2 articles (11/2000 - 03/2000)|
|9.||Ferreira, M A: 2 articles (11/2000 - 03/2000)|
|10.||Lipkin, G W: 2 articles (11/2000 - 03/2000)|
|1.||Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/01/1992 - "Immunofluorescence studies revealed the presence of immunoproteins and the A1AT protein isoelectric forms, PiM and PiZ, in the subendothelial region of glomerular basement membranes in A1AT patients with MPGN, Mes GN, and DPGN. "
06/01/1977 - "The association of familial liver disease, subepidermal immunoproteins, and membranoproliferative glomerulonephritis."
01/01/2010 - "This reduced the size of the potentially VEGF-C-blocking antibody fragment to only 14.6 kDa. Anti-VEGF-C V(H)-based immunoproteins hold promise to block the lymphangiogenic activity of VEGF-C, which would present a significant advance in inhibiting lymphatic-based metastatic spread of certain cancer types."
01/01/1991 - "Penetration of tumor tissue by antibodies and other immunoproteins."
01/15/1999 - "To evaluate a method for preventing the nephrotoxicity caused by the high renal accumulation of radiolabeled or toxin-conjugated small immunoproteins used for cancer therapy, we conjugated humanized anti-Tac Fab fragments with various numbers of glycolate molecules [glycolated Fab fragments (glyco-Fabs)] and separated the conjugates by means of ion-exchange columns into three fractions, depending on their isoelectric points (pIs). "
|3.||Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/01/1992 - "Although at one time accepted as a diagnostic characteristic of autoimmune thrombocytopenia (AITP), the initial euphoria was tempered over the last decade by the realisation that elevation of platelet associated immunoproteins was not pathognomonic of this disorder and that raised levels were seen in several other disease processes, sometimes even when platelet counts were normal. "
10/01/1983 - "4 children with idiopathic thrombocytopenic purpura were treated with high dose i.v. IgG. Platelet associated immunoproteins were determined with an Elisa technique. "
02/01/1998 - "The effectiveness of this treatment suggests that the predominant mechanism of thrombocytopenia in HIV-infected patients is increased destruction of platelets because of platelet-associated immunoproteins."
12/01/1977 - "Two patients with SLE and thrombocytopenia had an increase in both C3 and Ig, six patients with SLE who were not thrombocytopenic had normal amounts of membrane-bound C3 and IgG. In 5 patients, 3 with ITP and 2 with collagen vascular disease, both surface immunoproteins decreased with successful treatment of the thrombocytopenia."
11/01/2012 - "Classification and regression trees analysis was used to detect associations between the immunoproteins, clinical parameters and preterm preeclampsia. "
11/01/2012 - "To investigate cord blood and placental immunoproteins in order to find new clues on pathogenetic factors of preterm preeclampsia. "
03/01/2000 - "Analysis was made of 39 renal biopsy specimens with acute postinfective glomerulonephritis, later material from ten cases, four specimens from three women with pre-eclampsia, and 21 control specimens, with morphometry of glomeruli and immunohistological examination for immunoproteins and monocytes/macrophages. "
|1.||Immunoglobulin M (IgM)
|2.||Immunoglobulin G (IgG)
|5.||Immunoglobulin A (IgA)
|7.||Caspase 3 (Caspase-3)
|8.||Vascular Endothelial Growth Factor C
|9.||Transforming Growth Factor beta (TGF-beta)